Thomas Tu - 28 Feb 2022 Form 4 Insider Report for Inari Medical, Inc.

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
-$360,063
Form type
4
Filing time
02 Mar 2022, 17:24:58 UTC
Previous filing
22 Feb 2022
Next filing
30 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $1,823 +3,998 +5.1% $0.4560* 82,272 28 Feb 2022 Direct F1
transaction NARI Common Stock Sale $179,880 -1,998 -2.4% $90.03 80,274 28 Feb 2022 Direct F1, F2
transaction NARI Common Stock Sale $180,000 -2,000 -2.5% $90.00 78,274 28 Feb 2022 Direct F1
transaction NARI Common Stock Options Exercise $0.914 +2 +0% $0.4570* 78,276 01 Mar 2022 Direct F1
transaction NARI Common Stock Sale $180 -2 -0% $90.00 78,274 01 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise $1,827 -3,998 -1.9% $0.4570* 201,586 28 Feb 2022 Common Stock 3,998 $0.4570 Direct F1, F3
transaction NARI Stock Option Options Exercise $0.0914 -2 -0% $0.0457* 201,584 01 Mar 2022 Common Stock 2 $0.4570 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $90.00. to $90.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Option vested with respected with 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.